Global Non-PVC IV bags Market Size study, byProduct (Single Chamber, Multi Chamber), By Material (Ethylene Vinyl Acetate, Polypropylene, Copolyester Ether, And Others), By Content (Frozen Mixture, Liquid Mixture) and Regional Forecasts 2022-2028
Global Non-PVC IV bags Market is valued approximately USD 1.69 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11% over the forecast period 2022-2028.Increased demand for sophisticated IV containers and rising demand for preventive measures for faults such inappropriate dose distribution are two of the industry's main drivers. Fagron Sterile Services US (FSS), a 503B outsourcing company, stated in March 2021 has introduced a new platform to its product portfolio: intravenous (IV) bags. Drug-packaging material interactions, as well as transporting, managing, and disposing of IV containers, are all problems with standard IV containers. Non-PVC IV bags can prevent the majority of these problems. As a result, during the foreseeable period, demand for the same is expected to soar.Other factors driving market expansion include the growing presence of local producers in the worldwide market, strict restrictions prohibiting the use and disposal of PVC, and the development of healthcare infrastructure in emerging nations. Other factors driving the global non-PVC IV bag market include technological advancements in service quality and a growth in the number of hospitals worldwide. For instance, Sihuan Pharmaceutical Holdings Group Ltd and its affiliated company Beijing Ruiye Drugs Manufacture Co. Ltd jointly developed the ""non-PVC solid-liquid double chamber bag for ceftazidime/sodium chloride injection"" in May 2019. Similarly, Grifols began production of its innovative blood-collection systems factory in Brazil in November 2019, with a capacity of more than 10 million blood collection bags per year. High Cost of these bags is expected to hamper the market growth. In addition, technical developments in providing high-quality services and an increase in the number of hospitals around the world are two other factors propelling the Non-PVC IV bag market forward.
The key regions considered for the global Non-PVC IV Bags Marketstudy includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America had the largest share. In the United States, tight rules aimed at enhancing patient safety have boosted demand for non-PVC IV containers, which deliver treatment without putting patients at risk. Furthermore, the Asia Pacific area is expected to have the greatest CAGR. Increased foreign direct investment, as well as quick improvements in healthcare infrastructure, such as an increase in the number of hospitals, clinics, and blood banks, are all elements influencing the industry's growth.
Major market player included in this report are:
Baxter
B. Braun Melsungen AG
Pfizer, Inc. (Hospira)
Fresenius Kabi AG
JW Life Science
RENOLIT
PolyCine GmbH
Sealed Air
ANGIPLAST PVT. LTD
Shanghai Solve Care Co Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
ByProduct:
Single Chamber
Multi Chamber
By Material:
Ethylene Vinyle Acetate
Polypropylene
Copolyester ether
Others
By Content:
Frozen Mixture
Liquid Mixture
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Non-PVC IV bags Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
Baxter
B. Braun Melsungen AG
Pfizer, Inc. (Hospira)
Fresenius Kabi AG
JW Life Science
RENOLIT
PolyCine GmbH
Sealed Air
ANGIPLAST PVT. LTD
Shanghai Solve Care Co Ltd.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook